Navigation Links
Two New Jersey Hormone Therapy Lawsuits Dismissed
Date:7/14/2008

MADISON, N.J., July 14 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that Judge Jamie D. Happas of the New Jersey Superior Court in New Brunswick has granted Wyeth's motion for summary judgment in two hormone therapy cases that were scheduled for trial later this year. The court dismissed the cases of Bailey v. Wyeth, which was to have begun on September 15, and DeBoard v. Wyeth, which had an October 27 trial date. The plaintiffs in both cases alleged they developed breast cancer as a result of the use of Prempro(TM) and Premarin(R), hormone therapy products marketed by Wyeth, as well as Provera(R), a progestin product marketed by Upjohn.

In granting the motions, Judge Happas ruled, among other things, that the plaintiffs "failed to provide the specific type of evidence necessary to overcome the presumption of adequacy afforded [to] FDA-approved labeling" by New Jersey law and that the warnings were "adequate as a matter of law."

"We believe the court's ruling was a proper application of New Jersey law and is consistent with a growing body of law around the nation, rejecting challenges to FDA-approved labeling," says Lauren E. Handler, a partner with Porzio Bromberg & Newman, P.C., a New Jersey-based firm representing Wyeth in both cases.

About Wyeth

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. World Chemical Industry Has Decided to Gather at ChemOutsourcing Show on September 7-9 in New Jersey
2. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
3. E. coli Outbreak in New Jersey?
4. API and Raw Material Supply Concerns Focal Point of Pharma ChemOutsourcing Conference September 8-9 in New Jersey
5. Chemistry Outsourcing Conference Unveils 90-Speaker Conference Program to Take Place September 8-9 in New Jersey
6. StemCyte Locates East Coast Operations in New Jersey
7. BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey
8. Novo Nordisk Expands U.S. Headquarters in New Jersey
9. BioSpace New Jersey Career Fair Attracts Over 1,000 Bioscience Candidates
10. NicOx Opens U.S. Headquarters in New Jersey
11. Secure Symbology: Making New Jersey Proud While Saving Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... SynCardia Systems, Inc. ( http://www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... boasts more than 380,000 visitors annually, is featuring the ... the Freedom® portable driver as part of its $3 ... of its kind. , “BodyWorks combines the latest ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... announced,today that it has sold T-COTE, its proprietary ... sale, Sensient assumes all marketing and,sales responsibilities and ... will remain involved during the transition for,technical support. ... to the product,its specifications or method and location ...
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) ... announced today that its distributor,The Oyamo group has ... Mammography,System (CTLM(R)) for Jerusalem, Israel., (Logo: ... the import license from the Israel Ministry of,Health ...
... patients and caregivers from around the ... world ... GBS/CIDP Foundation,International will host its tenth international symposium on Guillain-Barre,Syndrome ... November 7-9, 2008. Over 250 medical professionals,current and former patients ...
Cached Biology Technology:Particle Sciences sells T-COTE(R) Line of Microfine Titanium Dioxides to Sensient 2Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel 2GBS/CIDP Foundation to Hold 10th International Symposium 2
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
(Date:5/23/2013)... Tomatoes, said to be the world,s most popular fruit, ... UK research with purple GM varieties. , "Working ... only by the addition of a specific compound, allows ... traits," said Professor Cathie Martin from the John Innes ... varieties with better flavour, health and shelf life characteristics ...
(Date:5/23/2013)... estrogen suppresses lipid synthesis in the liver, UC Irvine ... certain liver diseases. , With this finding, Dr. ... views in the field. Study results appear in the ... . , "The dogma in the steroid receptor field ... in the nucleus respond to steroid hormones by regulating ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... is a rare, devastating illness in which nerve cells that ... it, Lou Gehrigs disease or ALS (amyotrophic lateral sclerosis), is ... Hawking and Morrie Schwartz, about whom Mitch Alboms Tuesdays with ... cause is unknown. Figuring out why these people develop the ...
... March 3, 2008 On the evening of ... activities celebrating science and the spirit of discovery, nine ... two will be presented with prestigious Bower Awards. ... Nobel Prize, are awarded for outstanding achievements that have ...
... Research Awards were announced yesterday at an awards ceremony ... attended by shortlisted authors, eminent researchers from around the ... Research Awards, now in their second year, recognize excellence ... open access publication. The Awards celebrate the best medical ...
Cached Biology News:Motor neuron disease and toxic substances: Possible link? 2Motor neuron disease and toxic substances: Possible link? 3Science and technology take center stage this election year 2Science and technology take center stage this election year 3Science and technology take center stage this election year 4Science and technology take center stage this election year 5Science and technology take center stage this election year 6Excellence in open access research celebrated at BioMed Central awards dinner 2
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z36,327-8) or contact ...
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: